Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5

Conditions

Brain Neoplasms 6Glioblastoma 5Esophageal Neoplasms 3Childhood Brain Neoplasm 2Urinary Bladder Neoplasms 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic carcinoma, familial 1Pancreatic Intraductal Neoplasms 1Osteosarcoma 1Osteonecrosis 1Osteomyelitis 1Neurodegenerative Diseases 1Neoplasms 1Lung Carcinoma Metastatic in the Brain 1Liver Neoplasms 1Liver Cirrhosis 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Head and Neck Neoplasms 1Glioma 1Cranial Nerve Diseases 1Colorectal Neoplasms 1Chondrosarcoma 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × Ferrosoferric Oxide × Clear all
NCT07461948 2026-03-10

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

Jonsson Comprehensive Cancer Center

Phase 3 Recruiting
15 enrolled
CNS

Glioblastoma

NCT04900792 2025-12-03

XACT-Fe-GBM-01

University of Iowa

Phase 1 Active not recruiting
17 enrolled
CNS

Glioblastoma

NCT03347617 2025-09-09

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

OHSU Knight Cancer Institute

Phase 2 Terminated
52 enrolled 15 charts
CNS

Glioblastoma

NCT02359097 2022-03-17

Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

OHSU Knight Cancer Institute

Phase NA Completed
29 enrolled
CNS

Glioblastoma

NCT02466828 2018-04-18

qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.

Sunnybrook Health Sciences Centre

Phase EARLY_PHASE1 Completed
10 enrolled
CNS

Hypoxia, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡